Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec;4(1):6.
doi: 10.1186/s40203-016-0019-4. Epub 2016 Jul 7.

Classification model of amino acid sequences prone to aggregation of therapeutic proteins

Affiliations

Classification model of amino acid sequences prone to aggregation of therapeutic proteins

Monika Marczak et al. In Silico Pharmacol. 2016 Dec.

Abstract

Background: Total body clearance of biological drugs is for the most part dependent on the receptor mechanisms (receptor mediated clearance) and the concentration of antibodies aimed at administered drug - anti-drug-antibodies (ADA). One of the significant factors that induces the increase of ADA level after drug administration could be the aggregates present in the finished product or formed in the organism. Numerous attempts have been made to identify the sequence fragments that could be responsible for forming the aggregates - aggregate prone regions (APR).

Purpose: The aim of this study was to find physiochemical parameters specific to APR that would differentiate APR from other sequences present in therapeutic proteins.

Methods: Two groups of amino acid sequences were used in the study. The first one was represented by the sequences separated from the therapeutic proteins (n = 84) able to form APR. A control set (CS) consisted of peptides that were chosen based on 22 tregitope sequences.

Results: Classification model and four classes (A, B, C, D) of sequences were finally presented. For model validation Cooper statistics was presented.

Conclusions: The study proposes a classification model of APR. This consists in a distinction of APR from sequences that do not form aggregates based on the differences in the value of physicochemical parameters. Significant share of electrostatic parameters in relation to classification model was indicated.

Keywords: ADA; Aggregates; Immunogenicity; In silico; Proteins.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
A relationship between hydrogen bond acceptors (HBA) and ionization potential (IP-[eV – electronovolts]). APR aggregation prone regions (○; n = 84); tregitope sequences (□; n = 22), CS control set extracted from tregitopes (●; n = 42)
Fig. 2
Fig. 2
A separation of 4 classes (a, b, c, d) of dependencies and the relationship between aqueous solubility (QPlogS) and arithmetic expression value (AEx), Ln(AM − IP + AC × ROT) − (QPCaco − NON). APR aggregation prone regions (○; n = 84), CS control set extracted from tregitopes (●; n = 42), AC number of carboxylic acid groups, AM number of non-conjugated amine groups, IP ionization potential, ROT number of non-trivial (not CX3), non-hindered (not alkene, amide, small ring) rotatable bonds, QPCaco predicted apparent Caco-2 cell permeability, NON number of ring atoms not able to form conjugated aromatic systems

Similar articles

Cited by

References

    1. Agrawal NJ, Kumar S, Wang X. Aggregation in protein-based biotherapeutics: computational studies and tools to identify aggregation-prone regions. J Pharm Sci. 2011;100:5081–5095. doi: 10.1002/jps.22705. - DOI - PubMed
    1. Chennamsetty N, Voynov V, Kayser V, Helk B, Trout B. Design of therapeutic proteins with enhanced stability. PNAS. 2009;106:11937–11942. doi: 10.1073/pnas.0904191106. - DOI - PMC - PubMed
    1. Datta-Mannan A, Witcher DR, Tang Y, Watkins J, Wroblewski VJ. Monoclonal antibody clearance. Impact of modulating the interaction of IgG with the neonatal Fc receptor. J Biol Chem. 2007;282:1709–1717. doi: 10.1074/jbc.M607161200. - DOI - PubMed
    1. De Groot AS, Cousens L, Mingozzi F, Martin W. Tregitope peptides: the active pharmaceutical ingredient of IVIG? Clin Dev Immunol. 2013 - PMC - PubMed
    1. Dostalek M, Gardner I, Gurbaxani BM, Rose RH, Chetty M. Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies. Clin Pharmacokinet. 2012;52:83–124. doi: 10.1007/s40262-012-0027-4. - DOI - PubMed

LinkOut - more resources